CHEST Journal Podcasts

Latest Episodes:

Should BAL Be Routinely Performed in the Diagnostic Evaluation of IPF? Nov 22, 2017

Show notes

Athol U. Wells, MD, and Joshua J Mooney, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to debate whether bronchoalveolar lavage should be a standard diagnostic tool for IPF. The discussion centers on the lack of evidence-based agreement on the value of performing BAL.

IVIg to Treat Severe Refractory HIT Nov 22, 2017

Show notes

Anand Padmanabhan, MD, PhD, and editorialist Theodore Warkentin, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the paper by Padamanabhan et al, which describes outcomes in three patients with heparin-induced thrombocytopenia (HIT) who responded well to IVIg therapy.

Physician Assessment of Probability in Predicting Malignancy and Adherence with Guidelines Nov 22, 2017

Show notes

Nichole T. Tanner, MD, MSCR, FCCP, and editorialist Jonathan M. Iaccarino, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the accuracy of physician assessment in predicting malignancy in pulmonary nodules. Although adept at recognizing the pretest probability of malignancy, physicians would provide better patient care if they had followed guideline-recommended next steps in evaluation.

Wireless Pulmonary Artery Hemodynamic Monitoring for Pulmonary Hypertension? Nov 22, 2017

Show notes

Mark J. Zucker, MD, JD, FCCP, and Anne R. Hemnes, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to review the pros and cons of their Point/Counterpoint debate, “Should Wireless Pulmonary Artery Hemodynamic Monitoring Be Used to Monitor Patients With Pulmonary Hypertension?”

Hydrocortisone, Vitamin C, and Thiamine for Treatment of Sepsis Jun 06, 2017

Show notes

Paul E. Marik, MD, FCCP, and Editorialist Heleen M. Oudemans-van Straaten, MD, join CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss Dr. Marik and colleagues' retrospective study of the effectiveness in treating patients with severe sepsis and specific shock with the early use of intravenous vitamin C, together with corticosteroids and thiamine.

Cross-Disciplinary Analysis of Lymph Node Classification Apr 05, 2017

Show notes

Ahmed H. El-Sherief, MD, and editorialist Galit Aviram, MD, join CHEST podcast editor, D. Kyle Hogarth, MD, FCCP, to discuss the study by Dr. El-Sherief and others on the inconsistencies in lymph node classification and the need for a lymph node map that simultaneously communicates a standard set of lymph node station definitions in three languages—using the language of anatomic landmarks for surgeons, bronchoscopic landmarks for pulmonologists, and visual CT landmarks for radiologists.

Should Acute Fluid Resuscitation Be Guided Primarily by Inferior Vena Cava Ultrasound for Patients in Shock? Mar 14, 2017

Show notes

Gregory A. Schmidt, MD, FCCP, and Pierre Kory, MD, join CHEST podcast editor, D. Kyle Hogarth, MD, FCCP, to discuss their Point/Counterpoint debate on the value of inferior vena cava ultrasound to determine the use of acute fluid resuscitation for patients in shock.

Estimating Ten-Year Trends in Septic Shock Incidence Feb 06, 2017

Show notes

Chanu Rhee, MD, MPH, and Robert C. Hazy, MD, FCCP, join CHEST Podcast Editor D. Kyle Hogarth, MD, FCCP, to review and analyze the results of Dr. Rhee et al's research estimating incidences and mortality of septic shock over a ten-year period. Their results showed that the incidence has risen but mortality rates have fallen.

Risks for Patients Under Consideration for IVC Filters Dec 06, 2016

Show notes

Brian Funaki, MD, and Mark L. Lessne, MD, joint CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss this month's Point/Counterpoint debate: Do the Benefits Outweigh the Risks for Most Patients Under Consideration for Inferior Vena Cava Filters?

Autofluorescence Bronchochoscopy Detected Low Prevalence of High-Grade Lesions in LC Screening Nov 07, 2016

Show notes

Alain Tremblay, MD, and editorialist David E. Ost, MD, FCCP, joined CHEST Podcast Editor, D. Kyle Hogarth, MD, FCCP, to discuss the research by multi-center Canadian study by Tremblay et al that evaluated how well autofluorescence bronchochoscopy (AFB) detected high-grade lesions in patients at risk for lung cancer. Their study determined that too few CT occult cancers were detected to justify its addition into a lung cancer screening program.

Our TOPPODCAST Picks

Follow Us

Stay Connected

Related Podcasts

Links

Stay Connected

Our TOPPODCAST Picks

Follow Us

Stay Connected

CHEST Journal Podcasts

Related Podcasts

1

2

3

4

5

6